CORRELATION OF THE S100B PROTEIN AND THE DEGREE OF COGNITIVE IMPAIRMENTS IN PATIENTS WITH HIV INFECTION
https://doi.org/10.35266/2304-9448-2023-1-74-76
Abstract
The study aims to investigate the relation between cognitive impairments and neurospecific S100β protein in HIV patients. The quantitative content of the neurospecific S100β protein in the blood of 20 patients with HIV infection was determined using the Montreal scale (MoCa test). In all cases, HIV patients with cognitive impairment had an elevated level of S100β, while in some cases, patients with an increased level of the S100β protein did not suffer from cognitive decline. S100β may be a marker of central nervous system damage causing cognitive decline, but it is not clear whether elevated levels of S100β can be a predictor of future cognitive deficiency.
About the Authors
V. Z. Movsumov
Surgut State University, Surgut
Russian Federation
Russian Federation
Lecturer, Neurologist
E-mail: veli.mov94@gmail.com
L. P. Smertina
Surgut State University, Surgut
Russian Federation
Russian Federation
Candidate of Sciences (Medicine), Associate Professor, Neurologist
E-mail: Smertina@yandex.ru
References
1. Евзельман М. А., Снимщиков И. А., Королева Л. Я. и др. Неврологические осложнения ВИЧ-инфекции // Журн. неврологии и психиатрии им. С. С. Корсакова. 2015. Т. 115, № 3. С. 89–93.
2. Степанова Е. В., Леонова О. Н., Шеломов А. С. и др. Основные причины поражения головного мозга при ВИЧ-инфекции // Журн. инфектологии. 2017. Т. 9, № 4S1. C. 94.
3. Гайсина А. В., Магонов Е. П., Громова Е. А. и др. Патологические механизмы ВИЧ-ассоциированных нейрокогнитивных расстройств // Лучевая диагностика и терапия. 2016. № 2. С. 6–21.
4. Шеломов А. С., Степанова Е. В, Леонова О. Н. и др. Клиническая и радиологическая характеристики поражений центральной нервной системы у больных с ВИЧ-инфекцией // ВИЧ-инфекция и иммуносупрессии. 2017. Т. 9, № 1. С. 43–54.
5. Du Pasquier R. A., Jilek S., Kalubi M. et al. Marked Increase of the Astrocytic Marker S100B in the Cerebrospinal Fluid of HIV-infected Patients on LPV/r-monotherapy. AIDS 2015. Vol. 27, No. 2. Р. 203–210.
6. Nasreddine Z. S., Phillips N. A., Bédirian V., Charbonneau S., Whitehead V. et al. The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool for Mild Cognitive Impairment. Journal of the American Geriatrics Society. 2005. Vol. 53, No. 4. P. 695–699.
Review
For citations:
Movsumov V.Z., Smertina L.P. CORRELATION OF THE S100B PROTEIN AND THE DEGREE OF COGNITIVE IMPAIRMENTS IN PATIENTS WITH HIV INFECTION. Vestnik SurGU. Meditsina. 2023;16(1):74-76. (In Russ.) https://doi.org/10.35266/2304-9448-2023-1-74-76
Views:
153
Email this article 
